Western Pacific Region Index Medicus

DCK confers sensitivity of DCTD-positive cancer cells to oxidized methylcytidines.

Author: Ya-Hui ZHAO ¹ ; Wei JIANG ² ; Hai GAO ¹ ; Guo-Zheng PANG ¹ ; Yu-Shuang WU ¹ ; Yuan-Xian WANG ¹ ; Meng-Yao SHENG ¹ ; Jia-Ying XIE ¹ ; Wan-Ling WU ³ ; Zhi-Jian JI ² ; Ya-Rui DU ² ; Lei ZHANG ⁴ ; Xiao-Qin WANG ³ ; Colum P WALSH ⁵ ; Hai JIANG ² ; Guo-Liang XU ¹ ; Dan ZHOU ¹
Author Information

1. Shanghai Key Laboratory of Medical Epigenetics, Laboratory of Cancer Epigenetics, Institutes of Biomedical Sciences, Medical College of Fudan University, Chinese Academy of Medical Sciences (RU069), Shanghai 200032, China.
2. State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China.
3. Department of Hematology, Huashan Hospital of Fudan University, Shanghai 200040, China.
4. Department of Chemistry and Institutes of Biomedical Science, Shanghai Medical College, Fudan University, Shanghai 200032, China.
5. Genomic Medicine Research Group, Biomedical Sciences, Ulster University, Coleraine BT52 1SA, United Kingdom.
Publication Type:Research Support, Non-U.S. Gov't
MeSH: Humans; Gemcitabine; Neoplasms
From: Protein & Cell 2023;14(7):532-537
CountryChina
Language:English